| Device Classification Name |
Bcr/Abl1 Monitoring Test
|
| 510(k) Number |
K173492 |
| Device Name |
MRDx BCR-ABL Test, MRDx BCR-ABL Test Software |
| Applicant |
| MolecularMD Corporation |
| 1341 SW Custer Drive |
|
Portland,
OR
97219
|
|
| Applicant Contact |
Kevin Hawkins |
| Correspondent |
| MolecularMD Corporation |
| 1341 SW Custer Drive |
|
Portland,
OR
97219
|
|
| Correspondent Contact |
Kevin Hawkins |
| Regulation Number | 866.6060 |
| Classification Product Code |
|
| Date Received | 11/13/2017 |
| Decision Date | 12/22/2017 |
| Decision |
Substantially Equivalent - With Drug
(SESD) |
| Regulation Medical Specialty |
Molecular Genetics
|
| 510k Review Panel |
Pathology
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Traditional
|
| Clinical Trials |
NCT01698905 NCT01784068
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|